# Study of the Relationship Between rHuEPO Dose, Serum ADPN, and Mortality in Patients Beginning Hemodialysis (HD)

> **NCT00308698** · — · COMPLETED · sponsor: **Hamamatsu University**

## Conditions studied

- Renal Dialysis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00308698
- **Lead sponsor:** Hamamatsu University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2006-03-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00308698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00308698, "Study of the Relationship Between rHuEPO Dose, Serum ADPN, and Mortality in Patients Beginning Hemodialysis (HD)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00308698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*